These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
277 related items for PubMed ID: 6813992
1. Factor XII and other hemostatic protein abnormalities in nephrotic syndrome patients. Thompson AR. Thromb Haemost; 1982 Aug 24; 48(1):27-32. PubMed ID: 6813992 [Abstract] [Full Text] [Related]
2. Immunoquantitation of Hageman factor in urine and plasma of children with nephrotic syndrome. Hruby MA, Honig GR, Shapira E. J Lab Clin Med; 1980 Sep 24; 96(3):501-10. PubMed ID: 6772722 [Abstract] [Full Text] [Related]
3. [Hereditary deficiency of antithrombin III, protein C, protein S and factor XII in 121 patients with venous or arterial thrombosis]. Miljić P, Rolović Z, Elezović I, Antunović P, Stanojević M, Colović M. Srp Arh Celok Lek; 1999 Sep 24; 127(1-2):21-7. PubMed ID: 10377836 [Abstract] [Full Text] [Related]
4. Assessment of Actin FS and Actin FSL sensitivity to specific clotting factor deficiencies. Lawrie AS, Kitchen S, Purdy G, Mackie IJ, Preston FE, Machin SJ. Clin Lab Haematol; 1998 Jun 24; 20(3):179-86. PubMed ID: 9681235 [Abstract] [Full Text] [Related]
5. [Measurements of the activity of the coagulation factors VIII:C, IX,XI, and XII in cats]. Mischke R, Deniz A, Nolte I. Zentralbl Veterinarmed A; 1995 Oct 24; 42(8):513-20. PubMed ID: 8592897 [Abstract] [Full Text] [Related]
6. [Factor XII (Hageman factor) deficiency: a risk factor for development of thromboembolism. Incidence of factor XII deficiency in patients after recurrent venous or arterial thromboembolism and myocardial infarction]. Halbmayer WM, Mannhalter C, Feichtinger C, Rubi K, Fischer M. Wien Med Wochenschr; 1993 Oct 24; 143(2):43-50. PubMed ID: 8488686 [Abstract] [Full Text] [Related]
7. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity. Erem C. Clin Endocrinol (Oxf); 2006 Mar 24; 64(3):323-9. PubMed ID: 16487444 [Abstract] [Full Text] [Related]
8. Homozygous type I plasminogen deficiency. Mingers AM, Heimburger N, Zeitler P, Kreth HW, Schuster V. Semin Thromb Hemost; 1997 Mar 24; 23(3):259-69. PubMed ID: 9255907 [Abstract] [Full Text] [Related]
9. Intrinsic clotting factors in dependency of age, sex, body mass index, and oral contraceptives: definition and risk of elevated clotting factor levels. Luxembourg B, Schmitt J, Humpich M, Glowatzki M, Seifried E, Lindhoff-Last E. Blood Coagul Fibrinolysis; 2009 Oct 24; 20(7):524-34. PubMed ID: 19620844 [Abstract] [Full Text] [Related]
10. Kallikrein and prekallikrein levels in a large number of congenital clotting deficiencies and abnormalities. Patrassi GM, Martinelli S, Vianello C, Girolami A. Folia Haematol Int Mag Klin Morphol Blutforsch; 1982 Oct 24; 109(4):644-54. PubMed ID: 6184289 [Abstract] [Full Text] [Related]
11. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives. Bloemenkamp KW, Rosendaal FR, Helmerhorst FM, Koster T, Bertina RM, Vandenbroucke JP. Thromb Haemost; 1998 Sep 24; 80(3):382-7. PubMed ID: 9759614 [Abstract] [Full Text] [Related]